Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002980 · ClinicalTrials.gov registry record · Phase 1
Decitabine in Treating Patients With Melanoma or Other Advanced Cancer
A Phase 1 study, sponsored by California Cancer Consortium.
- Completed
- Registry status
- Phase 1
- Development phase
NCT00002980 is a Phase 1 study that has completed, run by California Cancer Consortium.
The verdict
NCT00002980, a Phase 1 study, has completed, sponsored by California Cancer Consortium.
- COMPLETED
- Registry status
- Phase 1
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of decitabine in treating patients with stage III or stage IV melanoma or other advanced cancer that has not responded to previous therapy.
Interventions
- DRUG decitabine
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00002980
The ClinicalTrials.gov registry entry for NCT00002980 describes a study currently listed as completed, categorized as Phase 1. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is California Cancer Consortium, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which decitabine is the first listed.
NCT00002980 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00002980 about?
NCT00002980 is a clinical study titled "Decitabine in Treating Patients With Melanoma or Other Advanced Cancer". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of decitabine in treating patients with stage III or stage IV melanoma or other advanced cancer that has not responded to previou...
What is the current status of trial NCT00002980?
This trial is currently completed. It is a Phase 1 study. The study started on 1997-05.
What interventions are being tested in trial NCT00002980?
The interventions under investigation include: decitabine (DRUG).
Who is sponsoring clinical trial NCT00002980?
This trial is sponsored by California Cancer Consortium, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.